Alzamend Neuro (ALZN) Total Current Liabilities (2020 - 2026)
Alzamend Neuro (ALZN) reported Total Current Liabilities of $3.83 million for fiscal Q3 2024 (quarter ended Jan 31, 2024), up 44.8% from $2.64 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Total Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2023 (ended Apr 30, 2023), Alzamend Neuro posted Total Current Liabilities of $2.87 million, up 146.4% from FY2022.
- Total Current Liabilities has a three-year compound annual growth rate of 42.5% (FY2020 to FY2023).
- By fiscal year, Total Current Liabilities came in at $1.16 million in FY2022 (+29.5%), $899,643 in FY2021 (-9.3%) and $992,306 in FY2020.
- The fiscal Q3 2024 figure ranks as the highest quarterly Total Current Liabilities in data going back to fiscal Q4 2020.
- Year over year, Total Current Liabilities gained in five of the last six quarters, with growth averaging 111.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 47.00 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 43.10 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.80 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -31.27 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 23.23 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 12.00 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 31.73 Bn |
| 10 | Alzamend Neuro | 6.51 Mn | -8.95 Mn | - | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 2.74 Mn |
| Apr 30, 2026 | 1.35 Mn |
| Jan 31, 2026 | 1.86 Mn |
| Oct 31, 2025 | 717,488.00 |
| Jul 31, 2025 | 983,311.00 |
| Apr 30, 2025 | 634,761.00 |
| Jan 31, 2025 | 725,851.00 |
| Oct 31, 2024 | 1.25 Mn |
| Jul 31, 2024 | 2.88 Mn |
| Apr 30, 2024 | 3.23 Mn |
| Jan 31, 2024 | 3.83 Mn |
| Oct 31, 2023 | 3.67 Mn |
| Jul 31, 2023 | 2.74 Mn |
| Apr 30, 2023 | 2.87 Mn |
| Jan 31, 2023 | 2.64 Mn |
| Oct 31, 2022 | 1.64 Mn |
| Jul 31, 2022 | 1.03 Mn |
| Apr 30, 2022 | 1.16 Mn |
| Jan 31, 2022 | 466,977.00 |
| Oct 31, 2021 | 1.48 Mn |
API Access
Alzamend Neuro Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();